Dawn R. Mattoon
Director Ejecutivo en Mercy Bioanalytics, Inc. .
Cargos activos de Dawn R. Mattoon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Mercy Bioanalytics, Inc.
 Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Director/Miembro de la Junta | 15/02/2023 | - |
| Director Ejecutivo | 15/02/2023 | - | |
| Director de Operaciones | 11/07/2022 | 15/02/2023 |
Historial de carrera de Dawn R. Mattoon
Antiguos cargos conocidos de Dawn R. Mattoon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| QUANTERIX CORPORATION | Director Técnico/Científico/I+D | 01/02/2018 | - |
| Corporate Officer/Principal | 01/02/2018 | - | |
Cell Signaling Technology, Inc.
 Cell Signaling Technology, Inc. Medical SpecialtiesHealth Technology Cell Signaling Technology, Inc. manufactures and distributes research tools for cell function and diseases. It offers primary antibodies, activators and inhibitors, buffers and dyes, cellsimple, and cytokines. The company was founded in 1999 and is headquartered in Danvers, MA. | Corporate Officer/Principal | 01/07/2014 | 01/02/2018 |
Formación de Dawn R. Mattoon.
| Yale University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| QUANTERIX CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc. Medical SpecialtiesHealth Technology Cell Signaling Technology, Inc. manufactures and distributes research tools for cell function and diseases. It offers primary antibodies, activators and inhibitors, buffers and dyes, cellsimple, and cytokines. The company was founded in 1999 and is headquartered in Danvers, MA. | Health Technology |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
- Bolsa de valores
- Insiders
- Dawn R. Mattoon
- Experiencia
